Noven Pharmaceuticals Inc

Type: Company
Name: Noven Pharmaceuticals Inc
Nationality: United States
First reported Apr 16 2014 - Updated Apr 17 2014 - 4 reports

Noven Pharmaceuticals Inc. Announces Settlement Of Lidoderm® Patent Litigation

MIAMI & NEW YORK--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. today announced that it has entered into an agreement with Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. to settle all outstanding patent litigation related ... [Published BioSpace - Apr 17 2014]
First reported Apr 07 2014 - Updated Apr 07 2014 - 1 reports

Noven receives new US patent for thermoregulatory dysfunction treatment

Noven Pharmaceuticals, Inc., a specialty pharmaceutical company, has received a new patent from the US Patent and Trademark, entitled, method of treating thermoregulatory dysfunction with paroxetine. This method of use patent covers the company's Brisdelle ... [Published Individual.com - Apr 07 2014]
First reported Mar 25 2014 - Updated Mar 27 2014 - 3 reports

Noven Pharma's Brisdelle receives US patent to treat VMS associated with menopause

The US Patent and Trademark Office (USPTO) has issued US patent No. 8,658,663, entitled “method of treating thermoregulatory dysfunction with paroxetine” to Noven Pharmaceuticals, Inc. This method of use patent covers the company’s Brisdelle (paroxetine) ... [Published PharmaBiz - Mar 27 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

Actavis Announces Daytrana® Patent Challenge Settlement

By a News Reporter-Staff News Editor at Health & Medicine Week -- Actavis plc (NYSE: ACT) announced that it has entered into an agreement with Noven Pharmaceuticals, Inc. to settle all outstanding patent litigation related to Actavis' generic version ... [Published 4 Traders - Mar 26 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

Impending Lockup Expiration For Empire State Realty Could Lead To A Steep Fall In Share Price

SummaryThe 180-day lockup period, following the ESRT IPO, will come to an end on March 31, 2014. ESRT is a high-profile Manhattan REIT, whose holdings include the Empire State Building. The lockup expiration could provide a short opportunity as pre-IPO ... [Published Seeking Alpha - Mar 26 2014]
First reported Mar 25 2014 - Updated Mar 26 2014 - 1 reports

Kristin Chenoweth to Perform Live at VeritageMiami

-   Kristin Chenoweth, the Tony and Emmy award-winning star of Wicked , TV's The West Wing , Pushing Daisies and Glee , will perform live during the final night of VeritageMiami. The closing event, Dinner on the Diamond, takes place on Saturday, April ... [Published 4 Traders - Mar 25 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

Actavis Updates on Daytrana Patent Challenge Settlement

Actavis announced that it has entered into an agreement with Noven Pharmaceuticals, Inc. to settle all outstanding patent litigation related to Actavis' generic version of Daytrana (Methylphenidate Transdermal System).According to a release, Daytrana ... [Published 4 Traders - Mar 25 2014]
First reported Mar 20 2014 - Updated Mar 21 2014 - 3 reports

Actavis enters into agreement with Noven Pharmaceuticals on Daytrana generic

DUBLIN — Actavis earlier this week announced that it has entered into an agreement with Noven Pharmaceuticals to settle all outstanding patent litigation related to Actavis' generic version of Daytrana (methylphenidate transdermal system). Daytrana is ... [Published Drug Store News - Mar 21 2014]
First reported Mar 19 2014 - Updated Mar 20 2014 - 7 reports

Actavis Announces Daytrana Patent Challenge Settlement

DUBLIN - Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Noven Pharmaceuticals, Inc. to settle all outstanding patent litigation related to Actavis' generic ... ... [Published Big News Network - Mar 20 2014]
Entities: Actavis, Bosättning, Patent
First reported Feb 06 2014 - Updated Feb 06 2014 - 1 reports

Compliance Congress: Walking the Line

Pharma industry executives, FDA officials and Department of Justice attorneys speaking last week at CBI’s 11 th annual Pharmaceutical Compliance Congress (PCC) offered solutions and threats to companies hoping to avoid enforcement actions.Once an investigation ... [Published Pharmaceutical Executive - Feb 06 2014]
First reported Feb 04 2014 - Updated Feb 04 2014 - 1 reports

Court Report - Part II

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Novartis Pharmaceuticals Corp. et al. v. Noven Pharmaceuticals Inc. et al. 1:14-cv-00111; filed January 30, 2014 in the District Court ... [Published Patent Docs - Feb 04 2014]
First reported Jan 15 2014 - Updated Jan 15 2014 - 1 reports

Noven Pharma inks pact with Shionogi to co-promote Brisdelle capsules

Noven Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of prescription pharmaceutical products, has entered into an agreement with Shionogi Inc. to co-promote Brisdelle (paroxetine) ... [Published PharmaBiz - Jan 15 2014]

Quotes

...entertainer of Kristen Chenoweth's stature as part of our VeritageMiami festivities," said Richard D Fain, His Royal Corkscrew of VeritageMiami. "VeritageMiami is about offering our guests unique and memorable experiences and I believe having dinner on the infield of Marlins Park, while listening to the extraordinarily talented Kristen Chenoweth perform, will make for a one-of-a-kind evening."
"I am excited to join and eager to hit the ground running for Alcobra. As my background suggests, I spent a significant part of my career working in the ADHD therapeutic area and look forward to applying my skills in overseeing the clinical advancement of Alcobra's novel non-stimulant ADHD product, MG01CI" stated Dr. Rubin. As a Medical Director in Global Medical Affairs at Shire Pharmaceuticals, Dr...

More Content

All (27) | News (21) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Noven Pharmaceuticals Inc. Announces Settlement... [Published BioSpace - Apr 17 2014]
Noven enters into settlement agreement with End... [Published Individual.com - Apr 17 2014]
Noven Announces Settlement of Lidoderm(R) Paten... [Published Scottrade - Apr 16 2014]
Noven Announces Settlement of Lidoderm® Patent ... [Published Business Wire Health News - Apr 16 2014]
Noven receives new US patent for thermoregulato... [Published Individual.com - Apr 07 2014]
Noven Pharma's Brisdelle receives US patent to ... [Published PharmaBiz - Mar 27 2014]
Actavis Announces Daytrana® Patent Challenge Se... [Published 4 Traders - Mar 26 2014]
Impending Lockup Expiration For Empire State Re... [Published Seeking Alpha - Mar 26 2014]
Noven Pharmaceuticals announces issuance of new... [Published PBR - News - Mar 26 2014]
Kristin Chenoweth to Perform Live at VeritageMiami [Published 4 Traders - Mar 25 2014]
Noven Pharmaceuticals Announces Issuance of New... [Published PR Newswire: Policy & Public Interest - Mar 25 2014]
Actavis Updates on Daytrana Patent Challenge Se... [Published 4 Traders - Mar 25 2014]
Actavis enters into agreement with Noven Pharma... [Published Drug Store News - Mar 21 2014]
Actavis settles generic Daytrana patent litigat... [Published PharmaBiz - Mar 21 2014]
Actavis Announces Daytrana Patent Challenge Set... [Published Big News Network - Mar 20 2014]
Actavis to settle patent litigation of Daytrana... [Published Pharmaceutical Business Review - Mar 20 2014]
Actavis, Noven reach settlement in Daytrana pat... [Published LegalNewsLine.com - Mar 20 2014]
Actavis in Daytrana patent settlement [Published Pharma Letter - Mar 20 2014]
Actavis readies Daytrana generic following pate... [Published Chain Drug Review - Mar 20 2014]
Actavis Announces Daytrana Patent Challenge Set... [Published PharmaceuticalProcessing - Mar 19 2014]
Actavis Announces Daytrana® Patent Challenge Se... [Published Barchart - Mar 19 2014]
Actavis Announces Daytrana® Patent Challenge Se... [Published PR Newswire: Policy & Public Interest - Mar 19 2014]
Compliance Congress: Walking the Line [Published Pharmaceutical Executive - Feb 06 2014]
Court Report - Part II [Published Patent Docs - Feb 04 2014]
Noven Pharma inks pact with Shionogi to co-prom... [Published PharmaBiz - Jan 15 2014]
First and Only FDA-Approved, Non-Hormonal Treat... [Published PR Newswire - Nov 05 2013]
Alcobra Ltd. Appoints Dr. Jonathan Rubin as Chi... [Published GlobeNewswire - Jul 30 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Noven Announces Settlement of Lidoderm® Patent ... [Published Business Wire Health News - Apr 16 2014]
MIAMI & NEW YORK--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. today announced that it has entered into an agreement with Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. to settle all outstanding patent litigation related ...
Noven Pharmaceuticals announces issuance of new... [Published PBR - News - Mar 26 2014]
Noven Pharmaceuticals has announced that the US Patent and Trademark Office has issued US Patent No. 8,658,663, entitled ‘Method Of Treating Thermoregulatory Dysfunction With Paroxetine’. ...
Noven Pharmaceuticals Announces Issuance of New... [Published PR Newswire: Policy & Public Interest - Mar 25 2014]
MIAMI and NEW YORK, March 25, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc. today announced the U.S. Patent and Trademark Office has issued U.S. Patent No. 8,658,663, entitled "Method Of Treating Thermoregulatory Dysfunction With Paroxetine." This ...
Actavis Announces Daytrana® Patent Challenge Se... [Published PR Newswire: Policy & Public Interest - Mar 19 2014]
DUBLIN, March 19, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Noven Pharmaceuticals, Inc. to settle all outstanding patent litigation related to Actavis' generic version of Daytrana® (Methylphenidate ...
Court Report - Part II [Published Patent Docs - Feb 04 2014]
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Novartis Pharmaceuticals Corp. et al. v. Noven Pharmaceuticals Inc. et al. 1:14-cv-00111; filed January 30, 2014 in the District Court ...
1

Press Releases

sort by: Date | Relevance
First and Only FDA-Approved, Non-Hormonal Treat... [Published PR Newswire - Nov 05 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.